Skip to main content

Celcuity Inc.

CELC
Exchange
Nasdaq
Industry
Services-Medical Laboratories
SEC CIK
0001603454

In the last 90 days, Celcuity Inc. insiders filed 0 open-market purchases and 1 sale; 273 institutions reported holding it in 13F filings for Q2 2026, worth $5.95B in total; no superinvestor holds it.

Q4 2022 vs. Q3 2022

How the institutions holding Celcuity Inc. changed between Q3 2022 and Q4 2022.

All holders in Q4 2022All holders in Q3 2022

13F holders of CELC: Q3 2022 compared with Q4 2022
MeasureQ3 2022Q4 2022Change
Holders3039+9
Shares4.80M11.2M+6.40M (+133.3%)
Value$48.2M$156.8M+$108.6M (+225.3%)

New holders (10)

Institutions that held Celcuity Inc. at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to CELC in Q4 2022
InstitutionSharesValue% of portfolio
VR Adviser, LLC2,105,386$29.5M4.97%
Ra Capital Management, L.P.1,400,001$19.6M0.40%
NEA Management Company, LLC1,250,001$17.5M0.98%
Dimensional Fund Advisors LP18,950$266.0K0.00%
Citadel Advisors LLC15,932$223.2K0.00%
683 Capital Management, LLC13,800$193.3K0.02%
Susquehanna International Group, LLP13,180$184.7K0.00%
JPMorgan Chase & Co4,970$70.0K0.00%
Freedom Wealth Alliance, LLC1,650$23.1K0.03%
Affiance Financial, LLC649$9.09K0.00%

Sold out (1)

Institutions that held Celcuity Inc. at the end of Q3 2022 and filed for Q4 2022 without it.

Institutions that sold out of CELC in Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
Bleichroeder LP50,000$502.0K